compared to the hexamethylmelamine , cyclophosphamide , methotrexate , and 5-fluorouracil ( hexa-caf ) regimen , the omission of methotrexate in chf did not detract from its antitumor activity and it was well tolerated with only mild to moderate toxicity .
C0062594
hexa-caf
C0016360
chf